-
PurposeTargeting vector for the human AAVS1 locus for insertion of traffic light reporter (TLR) construct
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 64215 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backboneAAVS1 SA-2A-puro-pA donor
-
Backbone manufacturerJaenisch lab (Addgene plasmid # 22075)
-
Modifications to backboneA CAG-Venus+1-P2A+3-tagRFP+3 cassette was cloned into SalI & NotI sites of AAVS1-SA-2A-Puro targeting vector (Addgene plasmid# 22075). The defective Venus (codons 117–152 replaced by a 52-bp segment derived from mouse Rosa26 locus) and a 56-bp segment from the mouse Rab38 gene were linked via T2A peptide to TagRFP in a 2-bp shifted reading frame (+3).
-
Vector typeHuman targeting
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nametraffic light reporter (TLR)
-
Alt nameAAVS1 targeting vector
-
Alt namepAAVS1-TLR donor
-
SpeciesH. sapiens (human)
-
Mutationsee publication for details
-
GenBank IDS51329.1
-
Entrez GeneAAVS1 (a.k.a. AAV)
- Promoter CAG
Cloning Information
- Cloning method Unknown
- 5′ sequencing primer M13pUC-rev
- 3′ sequencing primer M13pUC-fwd (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
Articles Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pAAVS1-TLR targeting vector was a gift from Ralf Kuehn (Addgene plasmid # 64215 ; http://n2t.net/addgene:64215 ; RRID:Addgene_64215) -
For your References section:
Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells. Chu VT, Weber T, Wefers B, Wurst W, Sander S, Rajewsky K, Kuhn R. Nat Biotechnol. 2015 Mar 24. doi: 10.1038/nbt.3198. 10.1038/nbt.3198 PubMed 25803306